The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
The prostate is the major accessory sex gland of the male. It provides exocrine function, but it has no established endocrine or secretory function. Its secretion provides fluid that comprises 15% of the ejaculate. These secretions produce a volume-expanding vehicle for sperm, yet no reproductive function has been identified. The gland has been the subject of much study because it is the site of infection...
Benign prostatic hyperplasia (BPH) is the most common neoplasm in men and is a significant cause of urinary symptoms in the aging male (1). Although much is unknown about the pathophysiology of BPH, the condition results in a diminished quality of life for many patients. The symptoms of BPH can be broadly divided into obstructive and irritative components. The former symptoms include a weakened urinary...
A 68-year-old man was seen in the emergency room with a 4-d complaint of dribbling urination and lower abdominal discomfort. His medical history included hypertension controlled on two medications and benign prostatic hyperplasia (BPH) treated with an α1-receptor antagonist. The patient’s vital signs revealed a temperature of 99°F, blood pressure of 132/80, pulse of 65 beats per min, and respiratory...
The purpose of urodynamic testing is to reproduce the patient’s symptoms in a controlled laboratory setting. A variety of measurements (bladder and urethral pressures, urine flow rate, fluoroscopic imaging) are made, and based on these observations and the clinical acumen of the examining physician, a diagnosis can be found that explains the patient’s complaints. In men with lower urinary tract symptoms...
The development of benign prostatic hypertrophy (BPH) is common among aging men. Accompanying the development of BPH may be impairment of the bladder’s ability to store and empty urine. Symptoms may include frequent urination, urgent voiding, an intermittent and diminished urinary stream, straining to void, nocturia, and a sense of incomplete bladder emptying. Collectively, these symptoms may be referred...
Although transurethral resection of the prostate (TURP) has been the gold standard for management of symptomatic benign prostate hyperplasia (BPH) for more than 50 years, surgery is not appropriate for all patients. Issues such as risk of anesthesia, postoperative recovery time, potential complications associated with TURP, and a desire to avoid surgery lead many patients to pursue medical therapy...
There has been considerable interest over the past decade in the development of nonsurgical and minimally invasive therapies for benign prostatic hyperplasia (BPH), especially for patients who do not desire surgery or for those who are poor surgical candidates. Transurethral resection of the prostate (TURP) remains the most effective and durable endoscopic therapy for symptomatic BPH, but it has been...
Transurethral resection of the prostate (TURP) remains the gold standard for treatment of benign prostatic hyperplasia (BPH). Although this procedure is generally safe, patients require a spinal, epidural, or general anesthesia and often need several days of hospital stay. In addition, potential morbidity limits the use of TURP in high-risk patients. Pharmacotherapy has been recommended as a first...
Men often report increasing irritative and obstructive voiding symptoms with advancing age and believe this to be a normal process of aging. Whereas these urinary symptoms are common, they should not be viewed as normal. Fortunately, although the age-related processes that produce the changes in urinary symptoms may have significant impact on quality of life, there is little risk to the quantity of...
Medical therapies for benign prostatic hyperplasia (BPH) have been critically investigated by well-designed clinical trials, which is the current model for assessing the safety and efficacy of any treatment for BPH. Pivotal medical studies for BPH are prospective, multicenter, randomized, double-blind, and placebo-controlled (1,2). This study design is the accepted standard to assess clinical safety...
Benign prostatic hyperplasia (BPH) causes a multitude of urinary symptoms as a result of obstruction of the bladder outlet. There are many phytotherapeutic and pharmacologic agents to treat BPH. BPH is more likely to be managed initially by primary care physicians and internists (49% of cases) than by urologists (37%) (1). Furthermore, minimally invasive techniques such as transurethral microwave...
There are numerous abbreviations used to signify transurethral vaporization of the prostate: TVP, TUVP, TUEVP, and TUVRP. Regardless of which acronym is used, transurethral vaporization of the prostate entails the simultaneous vaporization, desiccation, and coagulation of prostatic tissue, using a rollerball or thick loop. TUVRP, which stands for transurethral vapor resection of the prostate specifically...
Injection of sclerosing solutions into the prostate for the treatment of benign prostatic hyperplasia (BPH) was reported early in the 20th century. Sclerosing solutions including phenol, glacial acetic acid, and glycerin were injected transperineally and were successful in four of nine patients reported by Broughton and Smith (1). However, this therapy was discontinued because of perineal pain occurring...
There are a variety of well-defined goals associated with the surgical management of benign prostatic hyperplasia (BPH) voiding dysfunction. It is imperative that the operative approach selected adequately correct all of the significant pathophysiologic effects of bladder neck obstruction, including the following: (1) recurrent urinary tract infections; (2) the development of bladder stones; (3) episodes...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.